|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
DeSantis C, Ma J, Bryan L and Jemal A:
Breast cancer statistics, 2013. CA Cancer J Clin. 64:52–62. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Huober J and Thürlimann B: The role of
combination chemotherapy in the treatment of patients with
metastatic breast cancer. Breast Care (Basel). 4:367–372. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cardoso F, Harbeck N, Fallowfield L,
Kyriakides S and Senkus E; ESMO Guidelines Working Group, : Locally
recurrent or metastatic breast cancer: ESMO Clinical Practice
Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 23
Suppl 7:vii11–vii19. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Valastyan S and Weinberg RA: Tumor
metastasis: Molecular insights and evolving paradigms. Cell.
147:275–292. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chaffer CL and Weinberg RA: A perspective
on cancer cell metastasis. Science. 331:1559–1564. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang J, Tian XJ, Zhang H, Teng Y, Li R,
Bai F, Elankumaran S and Xing J: TGF-β-induced
epithelial-to-mesenchymal transition proceeds through stepwise
activation of multiple feedback loops. Sci Signal. 7:ra912014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gutschner T and Diederichs S: The
hallmarks of cancer: A long non-coding RNA point of view. RNA Biol.
9:703–719. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Djebali S, Davis CA, Merkel A, Dobin A,
Lassmann T, Mortazavi A, Tanzer A, Lagarde J, Lin W, Schlesinger F,
et al: Landscape of transcription in human cells. Nature.
489:101–108. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mercer TR, Dinger ME and Mattick JS: Long
non-coding RNAs: Insights into functions. Nat Rev Genet.
10:155–159. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
van Bakel H and Hughes TR: Establishing
legitimacy and function in the new transcriptome. Brief Funct
Genomic Proteomic. 8:424–436. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Perkel JM: Visiting ‘noncodarnia’.
Biotechniques. 54:301–304. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fabian MR and Sonenberg N: The mechanics
of miRNA-mediated gene silencing: A look under the hood of miRISC.
Nat Struct Mol Biol. 19:586–593. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kong YW, Ferland-McCollough D, Jackson TJ
and Bushell M: microRNAs in cancer management. Lancet Oncol.
13:e249–e258. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Huarte M and Rinn JL: Large non-coding
RNAs: Missing links in cancer? Hum Mol Genet. 19:R152–R161. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gibb EA, Brown CJ and Lam WL: The
functional role of long non-coding RNA in human carcinomas. Mol
Cancer. 10:382011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Prensner JR and Chinnaiyan AM: The
emergence of lncRNAs in cancer biology. Cancer Discov. 1:391–407.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hauptman N and Glavač D: Long non-coding
RNA in cancer. Int J Mol Sci. 14:4655–4669. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wilusz JE, Sunwoo H and Spector DL: Long
noncoding RNAs: Functional surprises from the RNA world. Genes Dev.
23:1494–1504. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ernst C and Morton CC: Identification and
function of long non-coding RNA. Front Cell Neurosci. 7:1682013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Derrien T, Johnson R, Bussotti G, Tanzer
A, Djebali S, Tilgner H, Guernec G, Martin D, Merkel A, Knowles DG,
et al: The GENCODE v7 catalog of human long noncoding RNAs:
Analysis of their gene structure, evolution, and expression. Genome
Res. 22:1775–1789. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nie L, Wu HJ, Hsu JM, Chang SS, Labaff AM,
Li CW, Wang Y, Hsu JL and Hung MC: Long non-coding RNAs: Versatile
master regulators of gene expression and crucial players in cancer.
Am J Transl Res. 4:127–150. 2012.PubMed/NCBI
|
|
25
|
van Heesch S, van Iterson M, Jacobi J,
Boymans S, Essers PB, de Bruijn E, Hao W, MacInnes AW, Cuppen E and
Simonis M: Extensive localization of long noncoding RNAs to the
cytosol and mono- and polyribosomal complexes. Genome Biol.
15:R62014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang KC and Chang HY: Molecular mechanisms
of long noncoding RNAs. Mol Cell. 43:904–914. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Rinn JL and Chang HY: Genome regulation by
long noncoding RNAs. Annu Rev Biochem. 81:145–166. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Guttman M and Rinn JL: Modular regulatory
principles of large non-coding RNAs. Nature. 482:339–346. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mattick JS: The genetic signatures of
noncoding RNAs. PLoS Genet. 5:e10004592009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bergmann JH and Spector DL: Long
non-coding RNAs: Modulators of nuclear structure and function. Curr
Opin Cell Biol. 26:10–18. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Foroni C, Broggini M, Generali D and Damia
G: Epithelial-mesenchymal transition and breast cancer: Role,
molecular mechanisms and clinical impact. Cancer Treat Rev.
38:689–697. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Vanharanta S and Massagué J: Origins of
metastatic traits. Cancer Cell. 24:410–421. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lamouille S, Subramanyam D, Blelloch R and
Derynck R: Regulation of epithelial-mesenchymal and
mesenchymal-epithelial transitions by microRNAs. Curr Opin Cell
Biol. 25:200–207. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Brabletz T: To differentiate or not-routes
towards metastasis. Nat Rev Cancer. 12:425–436. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chaw SY, Majeed AA, Dalley AJ, Chan A,
Stein S and Farah CS: Epithelial to mesenchymal transition (EMT)
biomarkers-E-cadherin, beta-catenin, APC and Vimentin-in oral
squamous cell carcinogenesis and transformation. Oral Oncol.
48:997–1006. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Marsan M, Van den Eynden G, Limame R,
Neven P, Hauspy J, Van Dam PA, Vergote I, Dirix LY, Vermeulen PB
and Van Laere SJ: A core invasiveness gene signature reflects
epithelial-to-mesenchymal transition but not metastatic potential
in breast cancer cell lines and tissue samples. PLoS One.
9:e892622014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Jin L, Chen J, Li L, Li C, Chen C and Li
S: CRH suppressed TGFβ1-induced Epithelial-Mesenchymal Transition
via induction of E-cadherin in breast cancer cells. Cell Signal.
26:757–765. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Gumbiner BM: Regulation of
cadherin-mediated adhesion in morphogenesis. Nat Rev Mol Cell Biol.
6:622–634. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Gheldof A and Berx G: Cadherins and
epithelial-to-mesenchymal transition. Prog Mol Biol Transl Sci.
116:317–336. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Acloque H, Adams MS, Fishwick K,
Bronner-Fraser M and Nieto MA: Epithelial-mesenchymal transitions:
The importance of changing cell state in development and disease. J
Clin Invest. 119:1438–1449. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Oka H, Shiozaki H, Kobayashi K, Inoue M,
Tahara H, Kobayashi T, Takatsuka Y, Matsuyoshi N, Hirano S,
Takeichi M, et al: Expression of E-cadherin cell adhesion molecules
in human breast cancer tissues and its relationship to metastasis.
Cancer Res. 53:1696–1701. 1993.PubMed/NCBI
|
|
44
|
Schipper JH, Frixen UH, Behrens J, Unger
A, Jahnke K and Birchmeier W: E-cadherin expression in squamous
cell carcinomas of head and neck: Inverse correlation with tumor
dedifferentiation and lymph node metastasis. Cancer Res.
51:6328–6337. 1991.PubMed/NCBI
|
|
45
|
Derksen PW, Liu X, Saridin F, van der
Gulden H, Zevenhoven J, Evers B, van Beijnum JR, Griffioen AW, Vink
J, Krimpenfort P, et al: Somatic inactivation of E-cadherin and p53
in mice leads to metastatic lobular mammary carcinoma through
induction of anoikis resistance and angiogenesis. Cancer Cell.
10:437–449. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Onder TT, Gupta PB, Mani SA, Yang J,
Lander ES and Weinberg RA: Loss of E-cadherin promotes metastasis
via multiple downstream transcriptional pathways. Cancer Res.
68:3645–3654. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Mallini P, Lennard T, Kirby J and Meeson
A: Epithelial-to-mesenchymal transition: What is the impact on
breast cancer stem cells and drug resistance. Cancer Treat Rev.
40:341–348. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Chao Y, Wu Q, Acquafondata M, Dhir R and
Wells A: Partial mesenchymal to epithelial reverting transition in
breast and prostate cancer metastases. Cancer Microenviron.
5:19–28. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Moody SE, Perez D, Pan TC, Sarkisian CJ,
Portocarrero CP, Sterner CJ, Notorfrancesco KL, Cardiff RD and
Chodosh LA: The transcriptional repressor Snail promotes mammary
tumor recurrence. Cancer Cell. 8:197–209. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
De Craene B and Berx G: Regulatory
networks defining EMT during cancer initiation and progression. Nat
Rev Cancer. 13:97–110. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Lin T, Ponn A, Hu X, Law BK and Lu J:
Requirement of the histone demethylase LSD1 in Snai1-mediated
transcriptional repression during epithelial-mesenchymal
transition. Oncogene. 29:4896–4904. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Tong ZT, Cai MF, Wang XG, Kong LL, Mai SJ,
Liu YH, Zhang HB, Liao YJ, Zheng F, Zhu W, et al: EZH2 supports
nasopharyngeal carcinoma cell aggressiveness by forming a
co-repressor complex with HDAC1/HDAC2 and Snail to inhibit
E-cadherin. Oncogene. 31:583–594. 2012.PubMed/NCBI
|
|
53
|
Herranz N, Pasini D, Díaz VM, Francí C,
Gutierrez A, Dave N, Escrivà M, Hernandez-Muñoz I, Di Croce L,
Helin K, et al: Polycomb complex 2 is required for E-cadherin
repression by the Snail1 transcription factor. Mol Cell Biol.
28:4772–4781. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Dong C, Wu Y, Wang Y, Wang C, Kang T,
Rychahou PG, Chi YI, Evers BM and Zhou BP: Interaction with Suv39H1
is critical for Snail-mediated E-cadherin repression in breast
cancer. Oncogene. 32:1351–1362. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Dong C, Wu Y, Yao J, Wang Y, Yu Y,
Rychahou PG, Evers BM and Zhou BP: G9a interacts with Snail and is
critical for Snail-mediated E-cadherin repression in human breast
cancer. J Clin Invest. 122:1469–1486. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Polyak K and Weinberg RA: Transitions
between epithelial and mesenchymal states: Acquisition of malignant
and stem cell traits. Nat Rev Cancer. 9:265–273. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Yang J and Weinberg RA:
Epithelial-mesenchymal transition: At the crossroads of development
and tumor metastasis. Dev Cell. 14:818–829. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Dubrovska A, Kim S, Salamone RJ, Walker
JR, Maira SM, García-Echeverría C, Schultz PG and Reddy VA: The
role of PTEN/Akt/PI3K signaling in the maintenance and viability of
prostate cancer stem-like cell populations. Proc Natl Acad Sci USA.
106:pp. 268–273. 2009; View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Padua D and Massagué J: Roles of TGFbeta
in metastasis. Cell Res. 19:89–102. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Zhou BP and Hung MC: Wnt, hedgehog and
snail: Sister pathways that control by GSK-3beta and beta-Trcp in
the regulation of metastasis. Cell Cycle. 4:772–776. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Guo F, Kerrigan BC Parker, Yang D, Hu L,
Shmulevich I, Sood AK, Xue F and Zhang W: Post-transcriptional
regulatory network of epithelial-to-mesenchymal and
mesenchymal-to-epithelial transitions. J Hematol Oncol. 7:192014.
View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Ceppi P and Peter ME: MicroRNAs regulate
both epithelial-to-mesenchymal transition and cancer stem cells.
Oncogene. 33:269–278. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Dumont N and Tlsty TD: Reflections on
miRing effects in metastasis. Cancer Cell. 16:3–4. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Rinn JL, Kertesz M, Wang JK, Squazzo SL,
Xu X, Brugmann SA, Goodnough LH, Helms JA, Farnham PJ, Segal E and
Chang HY: Functional demarcation of active and silent chromatin
domains in human HOX loci by noncoding RNAs. Cell. 129:1311–1323.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Gupta RA, Shah N, Wang KC, Kim J, Horlings
HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, et al: Long
non-coding RNA HOTAIR reprograms chromatin state to promote cancer
metastasis. Nature. 464:1071–1076. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Kleer CG, Cao Q, Varambally S, Shen R, Ota
I, Tomlins SA, Ghosh D, Sewalt RG, Otte AP, Hayes DF, et al: EZH2
is a marker of aggressive breast cancer and promotes neoplastic
transformation of breast epithelial cells. Proc Natl Acad Sci USA.
100:pp. 11606–11611. 2003; View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Chisholm KM, Wan Y, Li R, Montgomery KD,
Chang HY and West RB: Detection of long non-coding RNA in archival
tissue: Correlation with polycomb protein expression in primary and
metastatic breast carcinoma. PLoS One. 7:e479982012. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Alves C Padua, Fonseca AS, Muys BR, de
Barros E Lima Bueno R, Bürger MC, de Souza JE, Valente V, Zago MA
and Silva WA Jr: Brief report: The lincRNA Hotair is required for
epithelial-to-mesenchymal transition and stemness maintenance of
cancer cell lines. Stem Cells. 31:2827–2832. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Zhang H, Cai K, Wang J, Wang X, Cheng K,
Shi F, Jiang L, Zhang Y and Dou J: MiR-7, inhibited indirectly by
lincRNA HOTAIR, directly inhibits SETDB1 and reverses the EMT of
breast cancer stem cells by downregulating the STAT3 pathway. Stem
Cells. 32:2858–2868. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Li JT, Wang LF, Zhao YL, Yang T, Li W,
Zhao J, Yu F, Wang L, Meng YL, Liu NN, et al: Nuclear factor of
activated T cells 5 maintained by Hotair suppression of miR-568
upregulates S100 calcium binding protein A4 to promote breast
cancer metastasis. Breast Cancer Res. 16:4542014. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Gokmen-Polar Y, Vladislav IT, Neelamraju
Y, Janga SC and Badve S: Prognostic impact of HOTAIR expression is
restricted to ER-negative breast cancers. Sci Rep. 5:87652015.
View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Sorensen KP, Thomassen M, Tan Q, Bak M,
Cold S, Burton M, Larsen MJ and Kruse TA: Long non-coding RNA
HOTAIR is an independent prognostic marker of metastasis in
estrogen receptor-positive primary breast cancer. Breast Cancer Res
Treat. 142:529–536. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Bhan A, Hussain I, Ansari KI, Kasiri S,
Bashyal A and Mandal SS: Antisense transcript long noncoding RNA
(lncRNA) HOTAIR is transcriptionally induced by estradiol. J Mol
Biol. 425:3707–3722. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Bhan A, Hussain I, Ansari KI, Bobzean SA,
Perrotti LI and Mandal SS: Bisphenol-A and diethylstilbestrol
exposure induces the expression of breast cancer associated long
noncoding RNA HOTAIR in vitro and in vivo. J Steroid Biochem Mol
Biol. 141:160–170. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Tao S, He H and Chen Q: Estradiol induces
HOTAIR levels via GPER-mediated miR-148a inhibition in breast
cancer. J Transl Med. 13:1312015. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Bartolomei MS, Zemel S and Tilghman SM:
Parental imprinting of the mouse H19 gene. Nature. 351:153–155.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Gabory A, Jammes H and Dandolo L: The H19
locus: Role of an imprinted non-coding RNA in growth and
development. Bioessays. 32:473–480. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Brannan CI, Dees EC, Ingram RS and
Tilghman SM: The product of the H19 gene may function as an RNA.
Mol Cell Biol. 10:28–36. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Giannoukakis N, Deal C, Paquette J,
Goodyer CG and Polychronakos C: Parental genomic imprinting of the
human IGF2 gene. Nat Genet. 4:98–101. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Soejima H and Higashimoto K: Epigenetic
and genetic alterations of the imprinting disorder
Beckwith-Wiedemann syndrome and related disorders. J Hum Genet.
58:402–409. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Ma C, Nong K, Zhu H, Wang W, Huang X, Yuan
Z and Ai K: H19 promotes pancreatic cancer metastasis by
derepressing let-7's suppression on its target HMGA2-mediated EMT.
Tumour Biol. 35:9163–9169. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Luo M, Li Z, Wang W, Zeng Y, Liu Z and Qiu
J: Long non-coding RNA H19 increases bladder cancer metastasis by
associating with EZH2 and inhibiting E-cadherin expression. Cancer
Lett. 333:213–221. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Tsang WP, Ng EK, Ng SS, Jin H, Yu J, Sung
JJ and Kwok TT: Oncofetal H19-derived miR-675 regulates tumor
suppressor RB in human colorectal cancer. Carcinogenesis.
31:350–358. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Li H, Yu B, Li J, Su L, Yan M, Zhu Z and
Liu B: Overexpression of lncRNA H19 enhances carcinogenesis and
metastasis of gastric cancer. Oncotarget. 5:2318–2329. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Lottin S, Adriaenssens E, Dupressoir T,
Berteaux N, Montpellier C, Coll J, Dugimont T and Curgy JJ:
Overexpression of an ectopic H19 gene enhances the tumorigenic
properties of breast cancer cells. Carcinogenesis. 23:1885–1895.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Adriaenssens E, Lottin S, Berteaux N,
Hornez L, Fauquette W, Fafeur V, Peyrat JP, Le Bourhis X,
Hondermarck H, Coll J, et al: Cross-talk between mesenchyme and
epithelium increases H19 gene expression during scattering and
morphogenesis of epithelial cells. Exp Cell Res. 275:215–229. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Berteaux N, Lottin S, Monte D, Pinte S,
Quatannens B, Coll J, Hondermarck H, Curgy JJ, Dugimont T and
Adriaenssens E: H19 mRNA-like noncoding RNA promotes breast cancer
cell proliferation through positive control by E2F1. J Biol Chem.
280:29625–29636. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Matouk IJ, Raveh E, Abu-lail R, Mezan S,
Gilo M, Gershtain E, Birman T, Gallula J, Schneider T, Barkali M,
et al: Oncofetal H19 RNA promotes tumor metastasis. Biochim Biophys
Acta. 1843:1414–1426. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Xue G, Restuccia DF, Lan Q, Hynx D,
Dirnhofer S, Hess D, Rüegg C and Hemmings BA: Akt/PKB-mediated
phosphorylation of Twist1 promotes tumor metastasis via mediating
cross-talk between PI3K/Akt and TGF-beta signaling axes. Cancer
discov. 2:248–259. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Vennin C, Spruyt N, Dahmani F, Julien S,
Bertucci F, Finetti P, Chassat T, Bourette RP, Le Bourhis X and
Adriaenssens E: H19 non coding RNA-derived miR-675 enhances
tumorigenesis and metastasis of breast cancer cells by
downregulating c-Cbl and Cbl-b. Oncotarget. 6:29209–29223.
2015.PubMed/NCBI
|
|
91
|
Ji P, Diederichs S, Wang W, Böing S,
Metzger R, Schneider PM, Tidow N, Brandt B, Buerger H, Bulk E, et
al: MALAT-1, a novel noncoding RNA and thymosin beta4 predict
metastasis and survival in early-stage non-small cell lung cancer.
Oncogene. 22:8031–8041. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Jiao F, Hu H, Han T, Yuan C and Wang L,
Jin Z, Guo Z and Wang L: Long noncoding RNA MALAT-1 enhances stem
cell-like phenotypes in pancreatic cancer cells. Int J Mol Sci.
16:6677–6693. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Lai MC, Yang Z, Zhou L, Zhu QQ, Xie HY,
Zhang F, Wu LM, Chen LM and Zheng SS: Long non-coding RNA MALAT-1
overexpression predicts tumor recurrence of hepatocellular
carcinoma after liver transplantation. Med Oncol. 29:1810–1816.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Zhang ZJ, Tong YQ, Wang JJ, Yang C, Zhou
GH, Li YH, Xie PL, Hu JY and Li GC: Spaceflight alters the gene
expression profile of cervical cancer cells. Chin J Cancer.
30:842–852. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Xu C, Yang M, Tian J, Wang X and Li Z:
MALAT-1: A long non-coding RNA and its important 3′ end functional
motif in colorectal cancer metastasis. Int J Oncol. 39:169–175.
2011.PubMed/NCBI
|
|
96
|
Ying L, Chen Q, Wang Y, Zhou Z, Huang Y
and Qiu F: Upregulated MALAT-1 contributes to bladder cancer cell
migration by inducing epithelial-to-mesenchymal transition. Mol
Biosyst. 8:2289–2294. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Zhao Z, Chen C, Liu Y and Wu C:
17β-Estradiol treatment inhibits breast cell proliferation,
migration and invasion by decreasing MALAT-1 RNA level. Biochem
Biophys Res Commun. 445:388–393. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Tano K and Akimitsu N: Long non-coding
RNAs in cancer progression. Front Genet. 3:2192012. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Xu S, Sui S, Zhang J, Bai N, Shi Q, Zhang
G, Gao S, You Z, Zhan C, Liu F and Pang D: Downregulation of long
noncoding RNA MALAT1 induces epithelial-to-mesenchymal transition
via the PI3K-AKT pathway in breast cancer. Int J Clin Exp Pathol.
8:4881–4891. 2015.PubMed/NCBI
|
|
101
|
Silva JM, Boczek N, Berres MW, Ma X and
Smith DI: LSINCT5 is over expressed in breast and ovarian cancer
and affects cellular proliferation. RNA Biol. 8:496–505. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Silva JM, Perez DS, Pritchett JR, Halling
ML, Tang H and Smith DI: Identification of long stress-induced
non-coding transcripts that have altered expression in cancer.
Genomics. 95:355–362. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Hassan S, Buchanan M, Jahan K,
Aguilar-Mahecha A, Gaboury L, Muller WJ, Alsawafi Y, Mourskaia AA,
Siegel PM, Salvucci O and Basik M: CXCR4 peptide antagonist
inhibits primary breast tumor growth, metastasis and enhances the
efficacy of anti-VEGF treatment or docetaxel in a transgenic mouse
model. Int J Cancer. 129:225–232. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Sobolik T, Su YJ, Wells S, Ayers GD, Cook
RS and Richmond A: CXCR4 drives the metastatic phenotype in breast
cancer through induction of CXCR2 and activation of MEK and PI3K
pathways. Mol Biol Cell. 25:566–582. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Yang P, Liang SX, Huang WH, Zhang HW, Li
XL, Xie LH, Du CW and Zhang GJ: Aberrant expression of CXCR4
significantly contributes to metastasis and predicts poor clinical
outcome in breast cancer. Curr Mol Med. 14:174–184. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Loewer S, Cabili MN, Guttman M, Loh YH,
Thomas K, Park IH, Garber M, Curran M, Onder T, Agarwal S, et al:
Large intergenic non-coding RNA-RoR modulates reprogramming of
human induced pluripotent stem cells. Nat Genet. 42:1113–1117.
2010. View
Article : Google Scholar : PubMed/NCBI
|
|
107
|
Zhang A, Zhou N, Huang J, Liu Q, Fukuda K,
Ma D, Lu Z, Bai C, Watabe K and Mo YY: The human long non-coding
RNA-RoR is a p53 repressor in response to DNA damage. Cell Res.
23:340–350. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Zhang Y, Xia J, Li Q, Yao Y, Eades G,
Gernapudi R, Duru N, Kensler TW and Zhou Q: NRF2/long noncoding RNA
ROR signaling regulates mammary stem cell expansion and protects
against estrogen genotoxicity. J Biol Chem. 289:31310–31318. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Wang Y, Xu Z, Jiang J, Xu C, Kang J, Xiao
L, Wu M, Xiong J, Guo X and Liu H: Endogenous miRNA sponge
lincRNA-RoR regulates Oct4, Nanog, and Sox2 in human embryonic stem
cell self-renewal. Dev Cell. 25:69–80. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Yin X, Zhang BH, Zheng SS, Gao DM, Qiu SJ,
Wu WZ and Ren ZG: Coexpression of gene Oct4 and Nanog initiates
stem cell characteristics in hepatocellular carcinoma and promotes
epithelial-mesenchymal transition through activation of Stat3/Snail
signaling. J Hematol Oncol. 8:232015. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Liu L, Zhang J, Fang C, Zhang Z, Feng Y
and Xi X: OCT4 mediates FSH-induced epithelial-mesenchymal
transition and invasion through the ERK1/2 signaling pathway in
epithelial ovarian cancer. Biochem Biophys Res Commun. 461:525–532.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Hu J, Guo H, Li H, Liu Y, Liu J, Chen L,
Zhang J and Zhang N: MiR-145 regulates epithelial to mesenchymal
transition of breast cancer cells by targeting Oct4. PLoS One.
7:e459652012. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Eades G, Wolfson B, Zhang Y, Li Q, Yao Y
and Zhou Q: lincRNA-RoR and miR-145 regulate invasion in
triple-negative breast cancer via targeting ARF6. Mol Cancer Res.
13:330–338. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Hashimoto S, Onodera Y, Hashimoto A,
Tanaka M, Hamaguchi M, Yamada A and Sabe H: Requirement for Arf6 in
breast cancer invasive activities. Proc Natl Acad Sci USA. 101:pp.
6647–6652. 2004; View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Sabe H, Hashimoto S, Morishige M, Ogawa E,
Hashimoto A, Nam JM, Miura K, Yano H and Onodera Y: The
EGFR-GEP100-Arf6-AMAP1 signaling pathway specific to breast cancer
invasion and metastasis. Traffic. 10:982–993. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Hou P, Zhao Y, Li Z, Yao R, Ma M, Gao Y,
Zhao L, Zhang Y, Huang B and Lu J: LincRNA-ROR induces
epithelial-to-mesenchymal transition and contributes to breast
cancer tumorigenesis and metastasis. Cell Death Dis. 5:e12872014.
View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Chen YM, Liu Y, Wei HY, Lv KZ and Fu P:
Linc-ROR induces epithelial-mesenchymal transition and contributes
to drug resistance and invasion of breast cancer cells. Tumour
Biol. 37:10861–10870. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Orom UA, Derrien T, Beringer M, Gumireddy
K, Gardini A, Bussotti G, Lai F, Zytnicki M, Notredame C, Huang Q,
et al: Long noncoding RNAs with enhancer-like function in human
cells. Cell. 143:46–58. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Gumireddy K, Li A, Yan J, Setoyama T,
Johannes GJ, Orom UA, Tchou J, Liu Q, Zhang L, Speicher DW, et al:
Identification of a long non-coding RNA-associated RNP complex
regulating metastasis at the translational step. EMBO J.
32:2672–2684. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
120
|
Hansji H, Leung EY, Baguley BC, Finlay GJ
and Askarian-Amiri ME: Keeping abreast with long non-coding RNAs in
mammary gland development and breast cancer. Front Genet.
5:3792014. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Watson JB and Sutcliffe JG: Primate
brain-specific cytoplasmic transcript of the Alu repeat family. Mol
Cell Biol. 7:3324–3327. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
122
|
Tiedge H, Chen W and Brosius J: Primary
structure, neural-specific expression, and dendritic location of
human BC200 RNA. J Neurosci. 13:2382–2390. 1993.PubMed/NCBI
|
|
123
|
Chen W, Böcker W, Brosius J and Tiedge H:
Expression of neural BC200 RNA in human tumours. J Pathol.
183:345–351. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Iacoangeli A, Lin Y, Morley EJ, Muslimov
IA, Bianchi R, Reilly J, Weedon J, Diallo R, Böcker W and Tiedge H:
BC200 RNA in invasive and preinvasive breast cancer.
Carcinogenesis. 25:2125–2133. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
De Leeneer K and Claes K: Non Coding RNA
Molecules as Potential Biomarkers in Breast Cancer. Adv Exp Med
Biol. 867:263–275. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Yuan JH, Yang F, Wang F, Ma JZ, Guo YJ,
Tao QF, Liu F, Pan W, Wang TT, Zhou CC, et al: A long noncoding RNA
activated by TGF-β promotes the invasion-metastasis cascade in
hepatocellular carcinoma. Cancer Cell. 25:666–681. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Li W and Kang Y: A new Lnc in metastasis:
Long noncoding RNA mediates the prometastatic functions of TGF-β.
Cancer Cell. 25:557–559. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Iguchi T, Uchi R, Nambara S, Saito T,
Komatsu H, Hirata H, Ueda M, Sakimura S, Takano Y, Kurashige J, et
al: A long noncoding RNA, lncRNA-ATB, is involved in the
progression and prognosis of colorectal cancer. Anticancer Res.
35:1385–1388. 2015.PubMed/NCBI
|
|
129
|
Saito T, Kurashige J, Nambara S, Komatsu
H, Hirata H, Ueda M, Sakimura S, Uchi R, Takano Y, Shinden Y, et
al: A long non-coding RNA activated by transforming growth
factor-beta is an independent prognostic marker of gastric cancer.
Ann Surg Oncol. 22 Suppl 3:915–922. 2015. View Article : Google Scholar
|
|
130
|
Kang Y, Siegel PM, Shu W, Drobnjak M,
Kakonen SM, Cordón-Cardo C, Guise TA and Massagué J: A multigenic
program mediating breast cancer metastasis to bone. Cancer Cell.
3:537–549. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Shi SJ, Wang LJ, Yu B, Li YH, Jin Y and
Bai XZ: LncRNA-ATB promotes trastuzumab resistance and
invasion-metastasis cascade in breast cancer. Oncotarget.
6:11652–11663. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Meijer D, van Agthoven T, Bosma PT, Nooter
K and Dorssers LC: Functional screen for genes responsible for
tamoxifen resistance in human breast cancer cells. Mol Cancer Res.
4:379–386. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Godinho MF, Sieuwerts AM, Look MP, Meijer
D, Foekens JA, Dorssers LC and van Agthoven T: Relevance of BCAR4
in tamoxifen resistance and tumour aggressiveness of human breast
cancer. Br J Cancer. 103:1284–1291. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Godinho M, Meijer D, Setyono-Han B,
Dorssers LC and van Agthoven T: Characterization of BCAR4, a novel
oncogene causing endocrine resistance in human breast cancer cells.
J Cell Physiol. 226:1741–1749. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
135
|
Xing Z, Lin A, Li C, Liang K, Wang S, Liu
Y, Park PK, Qin L, Wei Y, Hawke DH, et al: lncRNA directs
cooperative epigenetic regulation downstream of chemokine signals.
Cell. 159:1110–1125. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Xing Z, Lin C and Yang L: Unraveling the
therapeutic potential of the LncRNA-dependent noncanonical Hedgehog
pathway in cancer. Mol Cell Oncol. 2:e9989002015. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Xing Z, Park PK, Lin C and Yang L: LncRNA
BCAR4 wires up signaling transduction in breast cancer. RNA Biol.
12:681–689. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Richards EJ, Zhang G, Li ZP, Permuth-Wey
J, Challa S, Li Y, Kong W, Dan S, Bui MM, Coppola D, et al: Long
non-coding RNAs (LncRNA) regulated by transforming growth factor
(TGF) β: LncRNA-hit-mediated TGFβ-induced epithelial to mesenchymal
transition in mammary epithelia. J Biol Chem. 290:6857–6867. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
139
|
Liu B, Sun L, Liu Q, Gong C, Yao Y, Lv X,
Lin L, Yao H, Su F, Li D, et al: A cytoplasmic NF-κB interacting
long noncoding RNA blocks IκB phosphorylation and suppresses breast
cancer metastasis. Cancer Cell. 27:370–381. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Pandey GK, Mitra S, Subhash S, Hertwig F,
Kanduri M, Mishra K, Fransson S, Ganeshram A, Mondal T, Bandaru S,
et al: The risk-associated long noncoding RNA NBAT-1 controls
neuroblastoma progression by regulating cell proliferation and
neuronal differentiation. Cancer Cell. 26:722–737. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Pandey GK and Kanduri C: Fighting
Neuroblastomas with NBAT1. Oncoscience. 2:79–80. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Hu P, Chu J, Wu Y, Sun L, Lv X, Zhu Y, Li
J, Guo Q, Gong C, Liu B and Su S: NBAT1 suppresses breast cancer
metastasis by regulating DKK1 via PRC2. Oncotarget. 6:32410–32425.
2015.PubMed/NCBI
|
|
143
|
Cowling VH, D'Cruz CM, Chodosh LA and Cole
MD: c-Myc transforms human mammary epithelial cells through
repression of the Wnt inhibitors DKK1 and SFRP1. Mol Cell Biol.
27:5135–5146. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
144
|
Sato N, Yamabuki T, Takano A, Koinuma J,
Aragaki M, Masuda K, Ishikawa N, Kohno N, Ito H, Miyamoto M, et al:
Wnt inhibitor Dickkopf-1 as a target for passive cancer
immunotherapy. Cancer Res. 70:5326–5336. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
145
|
Xu WH, Liu ZB, Yang C, Qin W and Shao ZM:
Expression of dickkopf-1 and beta-catenin related to the prognosis
of breast cancer patients with triple negative phenotype. PLoS One.
7:e376242012. View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Hu P, Chu J, Wu Y, Sun L, Lv X, Zhu Y, Li
J, Guo Q, Gong C, Liu B and Su S: NBAT1 suppresses breast cancer
metastasis by regulating DKK1 via PRC2. Oncotarget. 6:32410–32425.
2015.PubMed/NCBI
|
|
147
|
Foulds CE, Tsimelzon A, Long W, Le A, Tsai
SY, Tsai MJ and O'Malley BW: Research resource: Expression
profiling reveals unexpected targets and functions of the human
steroid receptor RNA activator (SRA) gene. Mol Endocrinol.
24:1090–1105. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Li H, Zhu L, Xu L, Qin K, Liu C, Yu Y, Su
D, Wu K and Sheng Y: Long noncoding RNA linc00617 exhibits
oncogenic activity in breast cancer. Mol Carcinog. 56:3–17. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Shi Y, Lu J, Zhou J, Tan X, He Y, Ding J,
Tian Y, Wang L and Wang K: Long non-coding RNA Loc554202 regulates
proliferation and migration in breast cancer cells. Biochem Biophys
Res Commun. 446:448–453. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
150
|
He K and Wang P: Unregulated long
non-coding RNA-AK058003 promotes the proliferation, invasion and
metastasis of breast cancer by regulating the expression levels of
the γ-synuclein gene. Exp Ther Med. 9:1727–1732. 2015.PubMed/NCBI
|
